By using this website you allow us to place cookies on your computer. Please read our Privacy Policy for more details.
Publication Date: April 2002
Publisher: Families USA
Author(s):
Research Area: Health
Type: Brief
Abstract:
This issue brief describes loopholes in the 1984 "Drug Price Competition and Patent Term Restoration Act" (known as the Hatch-Waxman Amendments) that permit brand-name drug manufacturers to minimize competition by delaying the market entry of generic drugs